These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 2944926)

  • 1. Clinical prediction of outcome and lithium response in bipolar affective disorder.
    Mander AJ
    J Affect Disord; 1986; 11(1):35-41. PubMed ID: 2944926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is lithium justified after one manic episode?
    Mander AJ
    Acta Psychiatr Scand; 1986 Jan; 73(1):60-7. PubMed ID: 3962704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chart review of the impact of attention-deficit/hyperactivity disorder comorbidity on response to lithium or divalproex sodium in adolescent mania.
    State RC; Frye MA; Altshuler LL; Strober M; DeAntonio M; Hwang S; Mintz J
    J Clin Psychiatry; 2004 Aug; 65(8):1057-63. PubMed ID: 15323589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of relapse or recurrence in bipolar I disorder.
    Degenhardt EK; Gatz JL; Jacob J; Tohen M
    J Affect Disord; 2012 Feb; 136(3):733-9. PubMed ID: 22036802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Previous pattern of course of the illness as a predictor of response to lithium prophylaxis in bipolar patients.
    Maj M; Pirozzi R; Starace F
    J Affect Disord; 1989; 17(3):237-41. PubMed ID: 2529291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential efficacy of olanzapine and lithium in preventing manic or mixed recurrence in patients with bipolar I disorder based on number of previous manic or mixed episodes.
    Ketter TA; Houston JP; Adams DH; Risser RC; Meyers AL; Williamson DJ; Tohen M
    J Clin Psychiatry; 2006 Jan; 67(1):95-101. PubMed ID: 16426094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of lithium response in affective disorders.
    Ananth J; Pecknold JC
    J Clin Psychiatry; 1978 Feb; 39(2):95-100. PubMed ID: 344305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized, double-blind, placebo-controlled efficacy and safety study of quetiapine or lithium as monotherapy for mania in bipolar disorder.
    Bowden CL; Grunze H; Mullen J; Brecher M; Paulsson B; Jones M; Vågerö M; Svensson K
    J Clin Psychiatry; 2005 Jan; 66(1):111-21. PubMed ID: 15669897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid titration of mood stabilizers predicts remission from mixed or pure mania in bipolar patients.
    Goldberg JF; Garno JL; Leon AC; Kocsis JH; Portera L
    J Clin Psychiatry; 1998 Apr; 59(4):151-8. PubMed ID: 9590664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of affective psychoses response to lithium prophylaxis. The role of socio-demographic, clinical, psychological and biological variables.
    Maj M; Del Vecchio M; Starace F; Pirozzi R; Kemali D
    Acta Psychiatr Scand; 1984 Jan; 69(1):37-44. PubMed ID: 6422702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of carbamazepine and lithium on affective disorders.
    Okuma T
    Neuropsychobiology; 1993; 27(3):138-45. PubMed ID: 8232828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recurrence of mania after lithium withdrawal. Implications for the use of lithium in the treatment of bipolar affective disorder.
    Goodwin GM
    Br J Psychiatry; 1994 Feb; 164(2):149-52. PubMed ID: 8173817
    [No Abstract]   [Full Text] [Related]  

  • 13. Thyroid function in patients maintained on lithium.
    Hatterer JA; Kocsis JH; Stokes PE
    Psychiatry Res; 1988 Dec; 26(3):249-57. PubMed ID: 3146759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Possible prediction of the preventive use of lithium in affective psychoses based on a study of the erythrocyte index].
    Shvestka Ia; Nagunek K
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1977; 77(8):1227-9. PubMed ID: 899538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clonazepam treatment of five lithium-refractory patients with bipolar disorder.
    Aronson TA; Shukla S; Hirschowitz J
    Am J Psychiatry; 1989 Jan; 146(1):77-80. PubMed ID: 2643359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Minimum plasma lithium levels required for effective prophylaxis in DSM III bipolar disorder: a prospective study.
    Maj M; Starace F; Nolfe G; Kemali D
    Pharmacopsychiatry; 1986 Nov; 19(6):420-3. PubMed ID: 3797469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors associated with response to lithium prophylaxis in DSM III major depression and bipolar disorder.
    Maj M; Arena F; Lovero N; Pirozzi R; Kemali D
    Pharmacopsychiatry; 1985 Sep; 18(5):309-13. PubMed ID: 3931108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A pharmacoeconomic model of divalproex vs. lithium in the acute and prophylactic treatment of bipolar I disorder.
    Keck PE; Nabulsi AA; Taylor JL; Henke CJ; Chmiel JJ; Stanton SP; Bennett JA
    J Clin Psychiatry; 1996 May; 57(5):213-22. PubMed ID: 8626353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thyroid function and bipolar affective disorder.
    Joffe RT; Kutcher S; MacDonald C
    Psychiatry Res; 1988 Aug; 25(2):117-21. PubMed ID: 3140257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of interepisode symptoms and relapse in affective disorder patients treated with lithium carbonate.
    Goodnick PJ; Fieve RR; Schlegel A; Baxter N
    Am J Psychiatry; 1987 Mar; 144(3):367-9. PubMed ID: 3103474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.